The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial-Reference-Cited by-同舟云学术

The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial

Published:2018-10 Issue: Volume:Volume 10 Page:4363-4369
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Hu Yong-Hong,Wei Jia-Wang,Chang Hui^ORCID,Xiao Wei-Wei,Lin Jun-Zhong,Cai Mu-Yan,Cai Pei-Qiang,Kong Ling-Heng,Chen Gong,Pan Zhi-Zhong,Zeng Zhi-Fan^ORCID,Ding Pei-Rong,Gao Yuan-Hong^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of pathological complete response and prognosis in locally advanced rectal cancer;World Journal of Gastrointestinal Oncology;2024-06-15

2. Integrated Intensified Chemoradiation in the Setting of Total Neoadjuvant Therapy (TNT) in Patients with Locally Advanced Rectal Cancer: A Retrospective Single-Arm Study on Feasibility and Efficacy;Cancers;2023-02-01

3. Clinical significance of adjuvant chemotherapy for pathological complete response rectal cancer patients with acellular mucin pools after neoadjuvant chemoradiotherapy;Therapeutic Advances in Gastroenterology;2023-01

4. CEA levels predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer*;Oncology and Translational Medicine;2022-08

5. Combined Detection of RUNX3 and EZH2 in Evaluating Efficacy of Neoadjuvant Therapy and Prognostic Value of Middle and Low Locally Advanced Rectal Cancer;Frontiers in Oncology;2022-02-24